Completed NA INTERVENTIONAL 2-arm NCT03751501

Targeted Laser in Diabetic Macular Edema (TaLa-DME)

Photocoagulation of Capillary Macro-aneurysms in Addition to the Standard Treatment of Macular Edema Due to Diabetic Retinopathy. TaLa_DME

Sponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

Conditions Diabetic Retinopathy Macular Edema

Interventions Indocyanine green-Guided Targeted Laser photocoagulation Sham laser

Updated 6 times since 2018 Last updated: Apr 30, 2025 Started: Feb 12, 2019 Primary completion: Dec 11, 2024 Completion: Dec 11, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Diabetic Retinopathy and Macular Edema, this trial is completed. The trial is conducted by Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Jun 2025 — Present [monthly]

Completed NA

Status: Unknown → Completed
Sep 2024 — Jun 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2022 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Jan 2022 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Dec 2018 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

Data source: Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France